Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Prolonged-Use of Inhaled Gaseous Nitric Oxide (gNO) for a Single Adult With Non-Tuberculous Mycobacteria Infection

NCT03473314 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT03473314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03473314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Prolonged-Use of Inhaled Gaseous Nitric Oxide (gNO) for a Single Adult With Non-Tuberculous Mycobacteria Infection
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Completed
Start date
March 9, 2018
Completion date
July 21, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-tuberculous mycobacterial pneumonia